Cite

HARVARD Citation

    Qiu, J. et al. (2022). A fluorinated peptide with high serum- and lipid-tolerence for the delivery of siRNA drugs to treat obesity and metabolic dysfunction. Biomaterials. p. . [Online]. 
  
Back to record